Abstract
All fields of medicine have had to change and adapt in response to the COVID-19 pandemic. In this respect, frail and immunocompromised patients have been particularly affected. Such patients are commonly treated in oncology, a field that has witnessed a revolution in its protocols, as physicians and institutions address this new situation. This paper details the aspects of oncology that have been affected by the pandemic, in areas such as chemotherapy, surgery and radiotherapy, together with the sharp rise in the use of telemedicine. Some of these changes will probably be permanent and may even come to be seen as a positive outcome of the pandemic.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
